Cases | Canadian Lawyer

Thomas Laur

Hearing Date: 26 May 2025

Bayer Inc et al. v. Amgen Canada Inc

CourtFederal Court

Case NumberT-2137-23

Practice AreaIntellectual property

Firms InvolvedMcCarthy Tétrault LLP, Bennett Jones LLP
Hearing Date: 21 May 2025

Bayer Inc. et al. v. Amgen Canada Inc.

CourtFederal Court

Case NumberT-1921-23

Practice AreaIntellectual property

Firms InvolvedMcCarthy Tétrault LLP, Bennett Jones LLP
Hearing Date: 27 Sep 2024

Munchkin, Inc et al. v. Angelcare Canada Inc. et al.

CourtFederal Court of Appeal

Case NumberA-105-22

Practice AreaIntellectual property

Firms InvolvedOsler, Hoskin & Harcourt LLP, Bennett Jones LLP, Smart & Biggar LLP
Hearing Date: 27 Sep 2024

Angelcare Canada Inc. et al. v. Munchkin, Inc. et al.

CourtFederal Court of Appeal

Case NumberA-106-22

Practice AreaIntellectual property

Firms InvolvedSmart & Biggar LLP, Bennett Jones LLP
Hearing Date: 19 Mar 2024

Bayer Inc and Regeneron Pharmaceuticals, Inc v. Amgen Canada Inc

CourtFederal Court

Case NumberT-1917-23

Practice AreaIntellectual property

Firms InvolvedMcCarthy Tétrault LLP, Bennett Jones LLP
Hearing Date: 19 Mar 2024

Bayer Inc et al., v. Amgen Canada Inc

CourtFederal Court

Case NumberT-1918-23

Practice AreaIntellectual property

Firms InvolvedMcCarthy Tétrault LLP, Bennett Jones LLP

Showing 1 to 6 of 6 entries

1

MOST ACTIVE FIRMS

01

Gowling WLG

Case 311 | Deals 102

02

McCarthy Tétrault LLP

Case 271 | Deals 387

03

Borden Ladner Gervais LLP (BLG)

Case 245 | Deals 190

04

Fasken Martineau DuMoulin LLP

Case 222 | Deals 249

05

Miller Thomson LLP

Case 214 | Deals 69

RECENTLY ADDED DEALS

19 May 2025

Manulife launches $500 million fixed/floating subordinated debenture offering

19 May 2025

TerraVest launches $278.9 million common share offering to fund growth and reduce debt

18 May 2025

TotalEnergies secures Canadian LNG supply via Ksi Lisims deal, acquires stake in Western LNG

18 May 2025

Canadian Securities Exchange expands with full acquisition of Australia’s NSX

18 May 2025

Regeneron to acquire 23andMe assets for US$256 million

	
		OSZAR »